Trial Profile
RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFICACY OF TESTOSTERONE UNDECANOATE, METFORMIN, OR THE COMBINATION OF BOTH, FOR THE TREATMENT OF ISOLATED HYPOGONADOTROPIC HYPOGONADISM AND ERECTILE DYSFUNCTION IN OBESE MALES
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Mar 2013
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary) ; Metformin
- Indications Erectile dysfunction; Hypogonadism
- Focus Therapeutic Use
- 13 Mar 2013 Planned End Date changed to 25 Feb 2014.
- 13 Mar 2013 New trial record